Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02354092 · ClinicalTrials.gov registry record · NA
Paracervical Block for Pain Control With Osmotic Dilator Placement
A NA study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02354092: Clinical Trial NA study, sponsored by University of California, San Diego.
NCT02354092 is a NA study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02354092, a NA study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Cervical dilators are frequently used for preparation prior to second trimester surgical abortion. While their use decreases complications associated with surgical abortion, their placement is often uncomfortable for the patient. Currently there are no proven methods for reducing pain during osmotic dilator placement. The use of numbing medication around the cervix (paracervical block) may decrease this placement pain.
Primary Outcome
Measure of distance (mm) from the left ("no pain") on the 100-mm visual analog scale (VAS - reflecting magnitude of pain) recorded at time immediately after osmotic dilator placement. 0 mm=No Pain and 100 mm= worst possible pain. A higher score indicates a higher level of pain.
Interventions
- PROCEDURE Sham
- PROCEDURE Paracervical Block
- PROCEDURE Local anesthetic for tenaculum placement
- PROCEDURE Dilator Placement
- BEHAVIORAL Post-procedural assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2015-04-02 |
| Est. Completion | 2015-08-25 |
| Phase | NA |
Why NCT02354092 stopped before completion
NCT02354092 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Sham is the first listed.
NCT02354092 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02354092 about?
NCT02354092 is a clinical study titled "Paracervical Block for Pain Control With Osmotic Dilator Placement". Cervical dilators are frequently used for preparation prior to second trimester surgical abortion. While their use decreases complications associated with surgical abortion, their placement is often uncomfortable for the patient. Currently there are no proven methods for reducing pain during osmotic...
What is the current status of trial NCT02354092?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2015-04-02. Estimated completion is 2015-08-25.
What interventions are being tested in trial NCT02354092?
The interventions under investigation include: Sham (PROCEDURE), Paracervical Block (PROCEDURE), Local anesthetic for tenaculum placement (PROCEDURE), Dilator Placement (PROCEDURE), Post-procedural assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02354092?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02354092's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy